Suchergebnisse - "Davies, Michael"

PubPharm (65)

1

Clinical Features Associated with Outcomes and Biomarker Analysis of Dabrafenib plus Trametinib Treatment in Patients with BRAF-Mutant Melanoma Brain Metastases

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Wilmott, J. | Tawbi, H. | Engh, J. | +15

2

Clinical Activity of Mitogen-Activated Protein Kinase-Targeted Therapies in Patients With Non-V600 BRAF-Mutant Tumors

enthalten in: JCO precision oncology | 2022

von Dankner, M. | Wang, Y. | Fazelzad, R. | +26

3

Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy

enthalten in: Nature | 2022

von Vellano, C. | White, M. | Andrews, M. | +62

CommentIn: Cancer Discov. 2022 Aug 5;12(8):1835. - PMID 35748587

4

Efficacy and Safety of Trametinib in Non-V600 BRAF Mutant Melanoma : A Phase II Study

enthalten in: The oncologist | 2021

von Nebhan, C. | Johnson, D. | Sullivan, R. | +4

5

Targeted Therapy Given after Anti-PD-1 Leads to Prolonged Responses in Mouse Melanoma Models through Sustained Antitumor Immunity

enthalten in: Cancer immunology research | 2021

von Phadke, M. | Chen, Z. | Li, J. | +17

6

High sensitivity sanger sequencing detection of BRAF mutations in metastatic melanoma FFPE tissue specimens

enthalten in: Scientific reports | 2021

von Cheng, L. | Haydu, L. | Song, P. | +6

7

Pathological response and survival with neoadjuvant therapy in melanoma : a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC)

enthalten in: Nature medicine | 2021

von Menzies, A. | Amaria, R. | Rozeman, E. | +20

CommentIn: Nat Rev Clin Oncol. 2021 Apr;18(4):193. - PMID 33627793

8

Short-term treatment with multi-drug regimens combining BRAF/MEK-targeted therapy and immunotherapy results in durable responses in Braf-mutated melanoma

enthalten in: Oncoimmunology | 2021

von White, M. | Szczepaniak Sloane, R. | Witt, R. | +29

9

Inhibiting insulin and mTOR signaling by afatinib and crizotinib combination fosters broad cytotoxic effects in cutaneous malignant melanoma

enthalten in: Cell death & disease | 2020

von Das, I. | Chen, H. | Maddalo, G. | +6

10

Targeting BRD/BET proteins inhibits adaptive kinome upregulation and enhances the effects of BRAF/MEK inhibitors in melanoma

enthalten in: British journal of cancer | 2020

von Tiago, M. | Capparelli, C. | Erkes, D. | +5

1
2
3
4
5
6
7
Nächster »
[7]